Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
9,914,647
-
Share change
-
+216,438
-
Total reported value
-
$11,759,119
-
Price per share
-
$1.40
-
Number of holders
-
18
-
Value change
-
+$303,322
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q2 2024
As of 30 Jun 2024,
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,914,647 shares.
The largest 10 holders included
M&G Plc, Alphabet Inc., HSG Holding Ltd, DC Funds, LP, BlueCrest Capital Management Ltd, Baird Financial Group, Inc., Johns Hopkins University, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, and Ipswich Investment Management Co., Inc..
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.